[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-469992-105":59,"doc-detail-469992-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","biomarkers-poster-presentation-impaired-csf-clearance-contributes-to-the-retention-of-alzheimers-biomarkers-independent-of-blood-brain-barrier-dysfunction","BIOMARKERS - Poster Presentation - Impaired CSF Clearance Contributes to the Retention of Alzheimer’s Biomarkers Independent of Blood-Brain Barrier Dysfunction","","Background: The plasma-to-cerebrospinal fluid (CSF) biomarker ratio may reflect peptide clearance from the central nervous system, but its relationship to blood-brain barrier (BBB) alterations in Alzheimer’s disease remains unclear. Method: Data from 102 participants across the AD spectrum in the TRIAD cohort were analyzed using Lumipulse measurements of plasma/CSF neurofilament light chain (NfL) and p-tau181, with CSF/serum albumin as a BBB integrity marker. Result: Plasma p-tau181/CSF p-tau181 and plasma NfL/CSF NfL ratios were reduced in A+T+ individuals, indicating impaired CSF clearance without albumin-quotient differences. PET amyloid burden correlated with reduced ratios, while correlations with albumin quotient were absent. Conclusion: Impaired CSF clearance contributes to AD biomarker accumulation independently of BBB dysfunction.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/biomarkers-poster-presentation-impaired-csf-clearance-contributes-to-the-retention-of-alzheimers-biomarkers-independent-of-blood-brain-barrier-dysfunction/469992/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/biomarkers-poster-presentation-impaired-csf-clearance-contributes-to-the-retention-of-alzheimers-biomarkers-independent-of-blood-brain-barrier-dysfunction/469992.png","ImageObject",300,407,{"name":92,"@type":93},"MrHarris58","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-07","2026-09-30",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What biomarker ratios were examined in the study?","Question",{"text":112,"@type":113},"The study analyzed plasma-to-CSF ratios of neurofilament light chain (NfL) and p-tau181, and related them to amyloid PET measures across the AD spectrum.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was blood-brain barrier integrity assessed?",{"text":117,"@type":113},"Blood-brain barrier integrity was evaluated using the CSF/serum albumin quotient, where higher values indicate increased permeability.",{"name":119,"@type":110,"acceptedAnswer":120},"Is impaired CSF clearance linked to blood-brain barrier dysfunction in Alzheimer’s disease?",{"text":121,"@type":113},"No. Although reduced plasma/CSF biomarker ratios suggested impaired CSF clearance in A+T+ individuals, significant albumin-quotient differences and correlations with the ratios were not observed, indicating independence from BBB dysfunction.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},469992,1793089216,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":81,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":39,"preview_page_count":81,"preview_urls":144},687212988360,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","DOI: 10. 1002/alz70856_107658  \nBIOMARKERS  \nPOSTER PRESENTATION  \nBIOMARKERS (NON-NEUROIMAGING)  \nImpaired CSF Clearance Contributes to the Retention of Alzheimer’s Biomarkers Independent of Blood-Brain Barrier Dysfunction  \nTevy Chan1, 2, 3  Seyyed Ali Hosseini 1, 2, 3  Arthur C. Macedo 1, 2, 3  Lydia Trudel 1, 2, 3  Marina P Gonçalves3  Nesrine Rahmouni 1, 2, 3  Brandon J Hall 1, 2, 3   \nJoseph Therriault 1, 2, 3  Kely Monica Quispialaya Socualaya 1, 2, 3  Stijn Servaes3  Gleb Bezgin 1, 2, 3  Yansheng Zheng 1, 2, 3  Yi-Ting Wang2, 3, 4  Etienne Aumont2, 3, 5  Jaime Fernandez Arias 1, 2, 3  Ana Paula Bernardes Real2  Wan Lu Jia 1, 2, 3   \nRobert Hopewell 1, 2  Chris Hsiao 1  Paolo Vitali2, 4  Tharick A Pascoal6, 7  Pedro Rosa-Neto 1, 2, 3, 8  \n1 Montreal Neurological Institute, Montreal, QC, Canada  \n2 McGill University, Montreal, QC, Canada  \n3Translational Neuroimaging Laboratory, The McGill University Research Centre for Studies in Aging, Montréal, QC, Canada  \n4The McGill University Research Centre for Studies in Aging, Montreal, QC, Canada  \n5 Université du Québec à Montréal, Montréal, QC, Canada  \n6 University of Pittsburgh, Pittsburgh, PA, USA  \n7 Departments of Psychiatry and Neurology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA  \n8 McConnell Brain Imaging Centre, Montreal Neurological Institute, McGill University, Montreal, QC, Canada  \nCorrespondence  \nTevy Chan, Montreal Neurological Institute, Montreal, QC, Canada. [Email:](Email: tevy.chan@mail.mcgill.ca)[ tevy.chan@mail.mcgill.ca](Email: tevy.chan@mail.mcgill.ca)  \nAbstract  \nBackground: Ratio between plasma and cerebrospinal fluid (CSF) biomarkers might inform about the peptide clearance from the central nervous system (CNS) to the peripheral body compartments. However, whether this clearance is linked to bloodbrain barrier (BBB) alterations in Alzheimer’s disease (AD) remains unclear. In this study, we examined the ratio between plasma and CSF neurofilament light chain (NfL) and p-tau181 and its relationship with BBB permeability in individuals across the AD spectrum.  \nMethod: We analyzed data of 102 participants (median age 66 years, 54% female) from the Translational Biomarkers in Aging and Dementia (TRIAD) cohort. Plasma and CSF levels of NfL and p-tau181were measured using Lumipulse G1200(Fujirebio). The CSF/serum albumin quotient, a marker of BBB integrity, was calculated, where higher values indicate increased permeability. Mann-Whitney U test compared the biomarker ratios among ATN groups. Spearman’s correlation examined the association between the plasma/CSF biomarker ratios and amyloid PET (18 F-NAV4694) global standardized uptake value ratio (SUVR), and between plasma/CSF biomarker ratios and the albumin quotient.  \nResult: Plasma p-tau181/CSF p-tau181 ratio and plasma NfL/CSF NfL ratio were decreased inA+T+ individuals (Figure 1), suggesting impaired CSF clearance in AD. No  \nThis is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.  \n© 2025 The Alzheimer’s Association. Alzheimer’s & Dementia published by Wiley Periodicals LLC on behalf of Alzheimer’s Association.  \nAlzheimer’s Dement. 2025;21(Suppl. 2):e107658.  \n[https://doi.org/10.1002/alz70856_107658](https://doi.org/10.1002/alz70856_107658)  \nwi[leyonlinelibrary.com/journal/alz](leyonlinelibrary.com/journal/alz)  \n1of3  \nBIOMARKERS  \nsignificant differences in albumin quotient values were observed among ATN groups. Moreoever, increased amyloid burden on PET correlated with reduced plasma/CSFp-tau181 and NfL ratios (Figure 2), further supporting a link between amyloid pathology and impaired clearance mechanisms. Finally, no significant correlation was found between plasma/CSF p-tau181 and NfL ratios and albumin quotient (Figure 3), suggesting that CSF clearance deficit is independent of BBB integrity.  \nConclusion: Our results sup","cbCaiss1mi7FysSe","https://ap.wps.com/l/cbCaiss1mi7FysSe","pdf",618708,"English","# Abstract\n## Background\n## Method\n## Result\n## Conclusion","[{\"question\":\"What biomarker ratios were examined in the study?\",\"answer\":\"The study analyzed plasma-to-CSF ratios of neurofilament light chain (NfL) and p-tau181, and related them to amyloid PET measures across the AD spectrum.\"},{\"question\":\"How was blood-brain barrier integrity assessed?\",\"answer\":\"Blood-brain barrier integrity was evaluated using the CSF/serum albumin quotient, where higher values indicate increased permeability.\"},{\"question\":\"Is impaired CSF clearance linked to blood-brain barrier dysfunction in Alzheimer’s disease?\",\"answer\":\"No. Although reduced plasma/CSF biomarker ratios suggested impaired CSF clearance in A+T+ individuals, significant albumin-quotient differences and correlations with the ratios were not observed, indicating independence from BBB dysfunction.\"}]","BIOMARKERS - Poster Presentation - Impaired CSF Clearance Contributes to the Retention of Alzheimer’s Biomarkers Independent of Blood-Brain Barrier Dysfunction | PDF",1790776541,[145,149,153],{"page_no":8,"url":146,"width":147,"height":148},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-17/32df574e0cd05ecb7c04dfe8231eb6ba.webp",983,1291,{"page_no":14,"url":150,"width":151,"height":152},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-17/3d36dce04bd7eda6c108e30388908254.webp",982,1290,{"page_no":81,"url":154,"width":155,"height":156},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-17/63cad62f6f294e96694e94e39f66ed31.webp",981,1289]